HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 4, 1997, Pages 308-311

  Schechter, Mauro ^a   Moulton, Lawrence H ^b   Harrison, Lee H ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Coinfection; HIV; HTLV I; Viral load

Indexed keywords

ARTICLE; COMORBIDITY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS CHARACTERIZATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0030825674     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708010-00010     Document Type: Article

References (19)

1. Schechter M, Harrison LH, Halsey NA, et al. Co-infection with human T-cell lymphotropic virus type I and HIV in Brazil: impact on markers of HIV disease progression. JAMA 1994;271:353-7.
2. Desormeaux J, Halsey N, Coberly J, et al. Absence of an association between HTLV-I, tuberculosis, and PPD size in HIV-1 positive and HIV-1 negative adults [abstract MC 3243]. Presented at the Seventh International Conference on AIDS, Florence, 1991:358.
3. Moreira ED, Ribeiro TT, Swanson P, et al. Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J AIDS 1993;6:959-63.
4. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326:375-80.
5. Quinn TC, Zacarias FR, St. John RK, AIDS in the Americas: an emerging public health crisis. N Engl J Med 1989;320:1005-7.
6. Harrington WJ, Ucar A, Gill P, et al. Clinical spectrum of HTLV-I in South Florida. J AIDS 1995;8:466-73.
7. Fantry L, Dodging E, Auwaerter PG, Lederman HM. Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin Infect Dis 1995;21:1466-8.
8. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
9. Mellors J, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
10. Schechter M, Zajdenverg R, Machado LL, Pinto ME, Lima LAA, Peres MA. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J AIDS 1994;7:163-8.
11. Harrison LH, Quinn TC, Schechter M. Human T-cell lymphotropic virus type I does not increase HIV viral load in vivo. J infect Dis 1997;175:438-40.
12. Lal RB, Heneine W, Rudolph DL, et al. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol 1991;29:2253-8.
13. Hershow RC, Galai N, Fukuda K, et al. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis 1996; 174:309-17.
14. Visconti A, Visconti L, Bellocco R, Binkin N, Colucci G, Vernocchi L, Amendola M, Ciaci D. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1993;6:1228-37.
15. Harrison LH, Schechter M. HTLV-II and HIV disease progression [letter]. J Infect Dis 1997;176:308.
16. Hillsberg P, Wucherpfennig KW, Ausubel LJ, Calvo V, Bierer BE, Hafler DA. Characterization of HTLV-I in vivo infected T cell clones. J Immunol 1992;148:3256-63.
17. Villiger PM, Cronin MT, Amenomori T, Wachsman W, Lotz M. IL-6 production by human T lymphocytes: expression in HTLV-1-infected but not in normal T cells. J Immunol 1991;146:550-9.
18. Wucherpfennig KW, Hillsberg P, Richardson JH, Benjamin D. Hafler DA. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sci USA 1992:89:2110-4.
19. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996;276:146-54.